Aldose Reductase Inhibitors and Nanodelivery of Diabetic Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|12|4|326-336

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.12, Iss.4, 2012-04, pp. : 326-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose reductase inhibitors: therapeutic implications for diabetic complications

By Oates P.J.   Mylari B.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2095-2119

Informa Healthcare

Access to resources Recommend Favorite

Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 2, 2016-01 ,pp. : 120-162

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite